Salt-inducible kinase inhibition promotes the adipocyte thermogenic program and adipose tissue browning

Fubiao Shi1, Flaviane de Fatima Silva2, Dianxin Liu1

  • 1Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Molecular Metabolism
|June 15, 2023
PubMed
Abstract

Insights

Salt-inducible kinase 3 (SIK3) acts as a crucial switch in the norepinephrine-stimulated thermogenic program. Inhibiting SIK3 promotes adipose tissue browning and may offer therapeutic benefits for obesity and cardiometabolic diseases.

Area of Science:

  • Cell Biology
  • Metabolism
  • Signaling Pathways

Background:

  • Norepinephrine activates adipose tissue thermogenesis via a β-adrenergic receptor (βAR)-cAMP-PKA pathway.
  • Mechanistic target of rapamycin complex 1 (mTORC1) activation by protein kinase A (PKA) is essential for βAR-stimulated adipose tissue browning.
  • Downstream mechanisms of PKA-phosphorylated mTORC1 in thermogenesis remain unclear.

Purpose of the Study:

  • To elucidate the downstream events in the PKA-mTORC1 signaling cascade that drive adipose tissue thermogenesis.
  • To identify novel substrates and regulators of mTORC1 in the context of β-adrenergic stimulation.
  • To investigate the role of salt-inducible kinase 3 (SIK3) in regulating thermogenic gene expression.

Main Methods:

  • Proteomic analysis using Stable Isotope Labeling by/with Amino acids in Cell culture (SILAC) to profile protein phosphorylation in brown adipocytes.
  • Investigated SIK3 function through gene knockdown (shRNA) and overexpression studies.
  • Utilized pharmacological inhibitors of SIK and mTORC1, as well as CRISPR-mediated gene deletion.
  • Assessed histone deacetylase (HDAC) activity and protein acetylation.

Main Results:

  • SIK3 interacts with mTORC1 and is phosphorylated by PKA.
  • SIK3 inhibition or deficiency enhances basal and βAR-stimulated thermogenic gene expression (e.g., Ucp1, Pgc1α).
  • CRISPR-mediated Sik3 deletion increases HDAC activity and promotes thermogenic gene expression.
  • In vivo administration of a SIK inhibitor stimulates thermogenesis and adipose tissue browning in mice.

Conclusions:

  • SIK3 functions as a key phosphorylation-dependent switch in β-adrenergic-mediated adipose tissue thermogenesis.
  • Targeting SIKs presents a potential therapeutic strategy for obesity and associated cardiometabolic disorders.
  • Further research into the SIK family's role in thermoregulation is warranted.